HEATHER CLOUD: Open Payments
NPI 1780170795 · LONDON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$644 in 33 payments from 14 companies in 2025. Trend: 2023 $341 · 2024 $335 · 2025 $644
Food & beverage: $644
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $138 |
| Otsuka America Pharmaceutical, Inc. | 4 | $88 |
| Vanda Pharmaceuticals Inc. | 3 | $83 |
| Lilly USA, LLC | 4 | $62 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $47 |
| Janssen Pharmaceuticals, Inc | 2 | $46 |
| E.R. Squibb & Sons, L.L.C. | 2 | $39 |
| Axsome Therapeutics, Inc. | 2 | $36 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $23 |
| Alkermes, Inc. | 1 | $20 |
Products named: VRAYLAR, ABILIFY MAINTENA, MOUNJARO, HETLIOZ, CAPLYTA, SPRAVATO, QULIPTA, COBENFY.
Industry payments across KY — which companies pay providers there.
